By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk will target launches of its mega popular obesity shot Wegovy in markets where it already …
By Bhanvi Satija and Savyata Mishra (Reuters) – Weight loss was the talk of this earnings season, making names such as Wegovy, Ozempic and Mounjaro …
By Bansari Mayur Kamdar and Amruta Khandekar (Reuters) – Investors are exiting exchange traded funds (ETFs) that track medical technology and device firms due to …
(Reuters) -Shares of U.S. medical device makers rose on Monday as a potential hit from the cardiac benefits of Novo Nordisk’s weight-loss drug Wegovy was …
(Reuters) – Nestle shares were under pressure on Friday as investors weighed the potential impact of Novo Nordisk’s blockbuster weight-losing drug Wegovy and how it …
By Blake Brittain WASHINGTON (Reuters) – A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the …
By Maggie Fick LONDON (Reuters) – Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s weight-loss drug Wegovy as part of the …
By Elissa Welle NEW YORK (Reuters) – U.S. psychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used …
By Jennifer Rigby DUBLIN (Reuters) – Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting …